If you have been reading about REV-ERB agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-12-19. Numbers and descriptions here follow the published literature rather than marketing material.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
=== Ontario minimum wage === Tim Hortons became the subject of controversy after the raise of the minimum wage in Ontario from $11.60 to $14.00 an hour which was made effective January 2018. The minimum wage increase was strongly criticized by the Ontario Chamber of Commerce, Restaurants Canada, and the Canadian Franchise Association. Restaurant Brands International did not help franchisees offset the wage hike, refusing to reduce the supply costs that it charged Tim Hortons franchisees, nor did it permit franchisees to raise menu prices in order to offset the wage hikes (in contrast to McDonald's, Cara Foods and Starbucks who did allow menu price increases in Ontario to cope with the wage increases). Tim Hortons franchisees, many of them small business owners who employed an average of 35 staff (the wage hike would cost the franchisee $7,000 per employee a year), responded by cutting employee benefits such as paid breaks and contributions to health plans. In one case, owners posted a memo encouraging employees to contact the Ontario Premier, Kathleen Wynne, and indicate that they "will not vote Liberal in the coming Ontario election in June 2018." Wynne responded by saying "I'm happy to talk to any business owner about the minimum wage but taking it out on employees is not fair and not acceptable." Around 50 demonstrations were held across Canada, including 38 in Ontario, in response to the benefit cuts.
In 1995, the largest sperm bank in New York State was ordered to close (and no longer operate semen banks and blood banks), over the objections of its owner the Daxor Corporation and its president, CEO, and majority shareholder Joseph Feldschuh, by New York State Supreme Court Justice Harold Tompkins. The Justice found that Daxor had repeatedly endangered the public health over several years. A 1993 inspection had documented 517 violations by the sperm bank, including its failure to screen sperm donors properly for sexually transmitted diseases. Rather, the inspection showed that Daxor had, in fact, made available semen from men who had tested positive for hepatitis, chlamydia, and gonorrhea. Daxor employees told government investigators that Feldschuh had instructed them to make false entries on business records and to lie to investigators. Feldschuh claimed New York State Health Department officials were conspiring to shut down his business, sued them three times, appealed three times, and lost each of the six times. The Daxor sperm bank was sued for negligence by customers. In one case, a White mother sued the sperm bank because though her White terminally ill husband's sperm had been stored at the sperm bank, when she asked for the sperm and used it to artificially inseminate her, she ended up giving birth to a Black baby. In 2007 another mother settled her own claims against Daxor for $250,000, which she said was a fraction of the estimated $7 million in care that will be needed for both of her children.
== History == 4-HO-MET was first synthesized and discovered by Alexander Shulgin in the 1970s. It was first described in the scientific literature by David Repke and colleagues by 1981. Subsequently, 4-HO-MET was described by Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved) in 1997 as being- aside from its synthesis- indistinguishable from any other ethyl homologue. It was encountered as a novel recreational and designer drug in Europe by 2008 and recently in the United States in 2025.
=== Oil === One estimate for yield of oil from kernels is 250 L/ha (22 imperial gallons per acre). The oil can be used as a food supplement, as a base for cosmetics, and for hair and the skin. Seeds of Moringa can also be used in production of biofuel.
They are often used in kumbilappam or chakka-ada (ചക്ക അട), an authentic sweet from Kerala, infusing their characteristic flavor to the dumplings. When sold, they are often labeled as "Indian bay leaves", or just "bay leaf" , causing confusion with the leaf from the bay laurel, a tree of Mediterranean origin in a different genus; the appearance and aroma of the two are quite different. Bay laurel leaves are shorter and light- to medium-green in color, with one large vein down the length of the leaf, while tejpat leaves are about twice as long and wider, usually olive green in color, with three veins down the length of the leaf. There are five types of tejpat leaves and they impart a strong cassia- or cinnamon-like aroma to dishes, while the bay laurel leaf's aroma is more reminiscent of pine and lemon.
Sources: en.wikipedia.org
=== Microfractures of the fetal membranes === Throughout gestation the fetal membranes undergo remodeling to allow for the increase in size of the uterus. The remodeling of the fetal membranes occurs at both the level of the cells and the extracellular matrix (ECM). Structural abnormalities such as areas of where collagen has degraded, known as microfractures, have been observed in the amniotic membrane layer. Microfractures are characterised by:
It has been claimed that Russian security services organized a number of denial of service attacks as a part of their cyber-warfare against other countries, most notably the 2007 cyberattacks on Estonia and the 2008 cyberattacks on Russia, South Ossetia, Georgia, and Azerbaijan. One identified young Russian hacker said that he was paid by Russian state security services to lead hacking attacks on NATO computers. He was studying computer sciences at the Department of the Defense of Information. His tuition was paid for by the FSB. Russian, South Ossetian, Georgian and Azerbaijani sites were attacked by hackers during the 2008 South Ossetia War. In October 2016, Jeh Johnson the United States Secretary of Homeland Security and James Clapper the U.S. Director of National Intelligence issued a joint statement accusing Russia of interfering with the 2016 United States presidential election. The New York Times reported the Obama administration formally accused Russia of stealing and disclosing Democratic National Committee emails. Under U.S. law (50 U.S.C.Title 50 – War and National Defense, Chapter 15 – National Security, Subchapter III Accountability for Intelligence Activities) there must be a formal Presidential finding prior to authorizing a covert attack. Then U.S. vice president Joe Biden said on the American news interview program Meet The Press that the United States will respond. The New York Times noted that Biden's comment "seems to suggest that Mr. Obama is prepared to order – or has already ordered – some kind of covert action".
Successful bead beating is dependent not only on design features of the shaking machine (which take into consideration shaking oscillations frequency, shaking throw or distance, shaking orientation and vial orientation), but also the selection of correct bead size (0.1–6 mm (0.004–0.2 in) diameter), bead composition (glass, ceramic, steel) and bead load in the vial. In most laboratories, bead beating is done in batch sizes of one to twenty-four sealed, plastic vials or centrifuge tubes. The sample and tiny beads are agitated at about 2000 oscillations per minute in specially designed reciprocating shakers driven by high power electric motors. Cell disruption is complete in 1–3 minutes of shaking. Significantly faster rates of cell disruption are achieved with a bead beater variation called SoniBeast. Differing from conventional machines, it agitates the beads using a vortex motion at 20,000 oscillations per minute. Larger bead beater machines that hold deep-well microtiter plates also shorten process times, as do Bead Dispensers designed to quickly load beads into multiple vials or microplates. Pre-loaded vials and microplates are also available. All high energy bead beating machines warm the sample about 10 degrees per minute. This is due to frictional collisions of the beads during homogenization. Cooling of the sample during or after bead beating may be necessary to prevent damage to heat-sensitive proteins such as enzymes.
=== Natural disasters and conservation === Kennedy has advocated for natural disaster aid for Louisiana to address hurricane damage as a member of the Appropriations Committee. He worked to reform the National Flood Insurance Program because he believes flood insurance is too expensive for coastal communities, including those in Louisiana. In 2023, Kennedy called on FEMA to disclose the algorithm it uses to determine flood insurance prices after premiums increased rapidly under FEMA's Risk Rating 2.0, saying, "Since millions of Louisianians depend on the NFIP to protect their homes from natural disasters, FEMA must come clean about why premiums are skyrocketing under Risk Rating 2.0. In the meantime, my bills would ensure fairer rates for the people of Louisiana." As treasurer, Kennedy believed in investing in coastal restoration and conservation. He worked to ensure that settlement money from the BP oil spill was used for coastal protection and restoration. Kennedy also fought to protect tobacco settlement money that had been allocated toward coastal restoration after the governor proposed using the money to cover other state debts.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.